JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 18 No. 4 360-366
© 1977 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Komai, T.
Right arrow Articles by Reba, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Komai, T.
Right arrow Articles by Reba, R. C.

Estrogen Derivatives for the External Localization of Estrogen-Dependent Malignancy

Toru Komai, William C. Eckelman, Roger E. Johnsonbaugh, Anneke Mazaitis, Haru Kubota and Richard C. Reba

George Washington University, Washington, D.C.
National Naval Medical Center, Bethesda, Maryland

Correspondence: For reprints contact: William C. Eckelman, Div. of Nuclear Medicine, George Washington University, Washington, DC 20037.

ABSTRACT

Four radioiodinated estrogen derivatives were studied to determine their affinity for the estrogen-binding protein found in the cytosol of rabbit and rat uteri. In vitro determination of the binding properties by competitive-binding experiments and by sucrose-gradient centrifugation indicates that one of the derivatives, iodohexestrol, binds to the cytosol estrogen binding protein. This in vitro behavior was related to in vivo distribution. Studies in immature female rats showed high uterine uptake of iodohexestrol at 2 hr (1.69% dose/gm). Iodohexestrol also has a high nonspecific binding in both the blood and the uterine cytosol. Thyroxine can diminish the nonspecific binding in vitro; in vivo the prior injection of thyroxine increased the 2-hr uterus-to-blood ratio from 1.9 to 10.4. The in vitro receptor-assay system was helpful in predicting in vivo distribution.




This article has been cited by other articles:


Home page
ScienceHome page
R. Hochberg
Iodine-125--labeled estradiol: a gamma-emitting analog of estradiol that binds to the estrogen receptor
Science, September 14, 1979; 205(4411): 1138 - 1140.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1977 by the Society of Nuclear Medicine.